Helicobacter pylori Eradication Using Empirical Therapy in Symptomatic Pediatric Patients: A Multicenter Real-World Study From Colombia

Read full text Summarise with VIRAT
Authors: Jose Fernando Vera Chamorro, Carolina Alexandra Zambrano Pérez, Constanza Camargo, Natali González Rozó, Juan Riveros, Andrés Enríquez, Ailim Margarita Carías Domínguez, Michelle Higuera, Diana María Quimbayo Wilches, César Moreno, Luis Ramírez, Claudia Liliana Losada Gómez
+3 more Diego Blanco, Otto Gerardo Calderón-Guerrero, Mariana Vásquez
Cited by: 0
References: 24

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

(Hp) infection remains a major public health challenge in Colombia, a region with a high incidence of gastric cancer. Optimizing amoxicillin dosing and adherence to weight-based regimens are key modifiable factors to improve eradication. Objective This multicenter study aimed to evaluate real-world Hp eradication rates in Colombian children and identify independent predictors of treatment success. Methods Secondary analysis of the multicenter "LatamPed-Hp" REDCap registry in REDCap included 26 centers in 14 Colombian cities, including treatment-naïve children with confirmed Hp infection. Demographic data, clinical symptoms, and pharmacological regimens were recorded. Eradication was confirmed after four weeks post-treatment primarily via non-invasive methods. Factors associated with success were analyzed using bivariate tests and a multivariable logistic regression model. Results A total of 330 patients were included (mean age 11.0 ± 3.8 years; 52.7% female). The overall eradication rate was 81.8% (270/330). Bivariate analysis showed that success was significantly associated with treatment adherence (p < 0.001), absence of non-gastrointestinal comorbidities (p = 0.005), and adequate amoxicillin dosing (p = 0.017). In the multivariable model, adequate weight-based amoxicillin dosing was a robust independent predictor of success (adjusted odds ratio (aOR) 2.76; 95% confidence interval (CI): 1.11-6.86; p = 0.028). Adherence remained the strongest protective factor (aOR 48.99; p < 0.001), while non-gastrointestinal comorbidities increased the odds of failure (aOR 0.21; p < 0.001). The model demonstrated high accuracy (84.59%) and sensitivity (98.31%). Conclusion Eradication rates in Colombian children remain below international targets. Pharmacological precision, specifically adequate amoxicillin dosing, is a critical modifiable factor for success. Ensuring strict adherence to weight-based protocols and improving treatment compliance are essential strategies to optimize Hp eradication and reduce long-term gastric cancer risk in this population.

Fields of Study & Subjects

Helicobacter pylori-related gastroenterology studies Gastrointestinal disorders and treatments Gastrointestinal Bleeding Diagnosis and Treatment

Publication details

Journal / source
Cureus
Volume
18
Issue
3
Pages
e106089–e106089
Publication date
29 March 2026
Language
EN